设计,合成,生物评估和新型1,3-醇衍生物的化研究
Nguyen Duy Khanh1, Nguyen Thi Hong Anh2, Nguyen Van Son1
1Faculty of Chemical Emgineering (FCE), Industrial University of Ho Chi Minh City (IUH) 12 Nguyen Van Bao, Hanh Thong Ward Ho Chi Minh City Vietnam trannguyenminhan@iuh.edu.vn.
RSC advances
|January 12, 2026
概括
新型醇衍生物显示出有前途的抗菌,抗癌,抗炎和α-葡萄糖酶抑制活性. 化合物4l表现出有利的药理动力学,突出了药物开发的潜力.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 1,3-醇衍生物被认为具有多种生物活性.
- 探索新的异环基架对于识别新的治疗剂至关重要.
- 对于具有多个标药理学特征的化合物,存在持续的需求.
研究的目的:
- 为了合成和表征新型的1,3-thiazole衍生物.
- 为了评估合成的化合物对抗菌,抗癌,抗炎和α-葡萄糖酶抑制活性.
- 调查有前途的候选药物的分子相互作用和药理动力学特性.
主要方法:
- 合成和结构特征使用点,FT-IR,NMR和HR-MS.
- 使用MIC,MTT,α-葡萄糖酶抑制和NO试验进行生物查.
- 在分析包括分子对接和分子动力学模拟,以及ADMET预测.
主要成果:
- 化合物4e显示出强大的抗菌活性 (MIC = 83.5μM).
- 化合物4g对MCF-7,HepG2和A549细胞系表现出显著的抗癌活性 (IC50=2.6-6.6μM).
- 化合物4f表现出显著的抗炎活性 (IC50 = 15.4 ± 1.0μM).
- 化合物4a和4l显示出强大的α-葡萄糖酶抑制 (IC50 = 46 ± 2 μM和41 ± 2 μM,分别),表现优于阿卡尔.
- 分子对接和动力学模拟支持观察到的生物活动和结构稳定性.
- 化合物4l显示出有利的ADMET特性.
结论:
- 合成的醇衍生物具有显著的多目标生物活性.
- 化合物4l是进一步药物开发的有希望的候选物,因为它具有强大的α-葡萄糖酶抑制活性和有利的药理学特征.
- 这项研究突出了基于 thiazole 的多功能支架,用于开发新的治疗药物.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K


